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This is an official
CDC HEALTH UPDATE
Updated Interim U.S. Case Definition for Severe Acute Respiratory 
Syndrome (SARS)
The previous CDC SARS case definition (published May 20, 2003) has been updated as follows:
• In the Epidemiologic Criteria, the last date of illness onset for inclusion as reported case for Toronto, Canada is now 
"ongoing."
The updated interim U.S. case definition is below. The document is posted on the CDC website at
(http://www.cdc.gov/ncidod/sars/casedefinition.htm). CDC has reissued a travel alert for Toronto, Canada due to evidence of 
new transmission of SARS (http://www.cdc.gov/ncidod/sars/casedefinition.htm).
Clinical Criteria
• Asymptomatic or mild respiratory illness
• Moderate respiratory illness
—Temperature of >100.4° F (>38° C)*, and
—One or more clinical findings of respiratory illness (e.g., cough, shortness of breath, difficulty breathing, or 
hypoxia).
• Severe respiratory illness
—Temperature of >100.4° F (>38° C)*, and
—One or more clinical findings of respiratory illness (e.g., cough, shortness of breath, difficulty breathing, or 
hypoxia), and
— radiographic evidence of pneumonia, or 
— respiratory distress syndrome, or
—autopsy findings consistent with pneumonia or respiratory distress syndrome without an identifiable cause. 
Epidemiologic Criteria
• Travel (including transit in an airport) within 10 days of onset of symptoms to an area with current or previously 
documented or suspected community transmission of SARS (see Table), or
• Close contact5 within 10 days of onset of symptoms with a person known or suspected to have SARS
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Area First date o f illness onset for 
inclusion as reported casef
Last date o f illness onset for 
inclusion as reported casef
China (mainland) November 1, 2002 Ongoing
Hong Kong February 1, 2003 Ongoing
Hanoi, Vietnam February 1, 2003 May 25, 2003
Singapore February 1, 2003 Ongoing
Toronto, Canada April 23, 2003 Ongoing
Taiwan May 1, 2003 Ongoing
Laboratory Criteria1
• Confirmed
— Detection of antibody to SARS-CoV in specimens obtained during acute illness or >21 days after illness onset, or 
— Detection of SARS-CoV RNA by RT-PCR confirmed by a second PCR assay, by using a second aliquot of the 
specimen and a different set of PCR primers, or 
— Isolation of SARS-CoV.
• Negative
—Absence of antibody to SARS-CoV in convalescent serum obtained >21 days after symptom onset.
• Undetermined
— Laboratory testing either not performed or incomplete.
Case Classification**
• Probable case: meets the clinical criteria for severe respiratory illness of unknown etiology and epidemiologic criteria 
for exposure; laboratory criteria confirmed, negative, or undetermined.
• Suspect case: meets the clinical criteria for moderate respiratory illness of unknown etiology, and epidemiologic 
criteria for exposure; laboratory criteria confirmed, negative, or undetermined.
Exclusion Criteria
A case may be excluded as a suspect or probable SARS case if:
• An alternative diagnosis can fully explain the illness***
• The case was reported on the basis of contact with an index case that was subsequently excluded as a case of SARS
(e.g., another etiology fully explains the illness) provided other possible epidemiologic exposure criteria are not 
present
• A measured documented temperature of >100.4° F (>38° C) is preferred. However, clinical judgment should be used
when evaluating patients for whom a measured temperature of >100.4° F (>38° C) has not been documented. 
Factors that might be considered include patient self-report of fever, use of antipyretics, presence of 
immunocompromising conditions or therapies, lack of access to health care, or inability to obtain a measured 
temperature. Reporting authorities should consider these factors when classifying patients who do not strictly meet 
the clinical criteria for this case definition.
• Close contact is defined as having cared for or lived with a person known to have SARS or having a high likelihood of
direct contact with respiratory secretions and/or body fluids of a patient known to have SARS. Examples of close 
contact include kissing or embracing, sharing eating or drinking utensils, close conversation (<3 feet), physical 
examination, and any other direct physical contact between persons. Close contact does not include activities such 
as walking by a person or sitting across a waiting room or office for a brief period of time.
• The WHO has specified that the surveillance period for China should begin on November 1; the first recognized cases
in Hong Kong, Singapore and Hanoi(Vietnam) had onset in February 2003. The dates for Toronto and Taiwan are 
linked to CDC's issuance of travel recommendations.
• The last date for illness onset is 10 days (i.e., one incubation period) after removal of a CDC travel alert. The case
patient's travel should have occurred on or before the last date the travel alert was in place.
• Assays for the laboratory diagnosis of SARS-CoV infection include enzyme-linked immunosorbent assay, indirect
fluorescent-antibody assay, and reverse transcription polymerase chain reaction (RT-PCR) assays of appropriately 
collected clinical specimens (Source: CDC. Guidelines for collection of specimens from potential cases of SARS. 
Available at http://www.cdc.gov/ncidod/sars/specimen_collection_sars2.htm). Absence of SARS-CoV antibody from 
serum obtained <21 days after illness onset, a negative PCR test, or a negative viral culture does not exclude 
coronavirus infection and is not considered a definitive laboratory result. In these instances, a convalescent serum 
specimen obtained >21 days after illness is needed to determine infection with SARS-CoV. All SARS diagnostic 
assays are under evaluation.
• Asymptomatic SARS-CoV infection or clinical manifestations other than respiratory illness might be identified as more
is learned about SARS-CoV infection.
• Factors that may be considered in assigning alternate diagnoses include the strength of the epidemiologic exposure
criteria for SARS, the specificity of the diagnostic test, and the compatibility of the clinical presentation and course 
of illness for the alternative diagnosis.
For more information, visit http://www.cdc.gov/ncidod/sars or call the CDC public response hotline at (888) 246-2675
(English), (888) 246-2857 (Español), or (866) 874-2646 (TTY)
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling 
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